Toshiro Mizuno

1.9k total citations
69 papers, 1.4k citations indexed

About

Toshiro Mizuno is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshiro Mizuno has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshiro Mizuno's work include HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (8 papers) and Congenital heart defects research (7 papers). Toshiro Mizuno is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (8 papers) and Congenital heart defects research (7 papers). Toshiro Mizuno collaborates with scholars based in Japan, United States and Poland. Toshiro Mizuno's co-authors include Hiroyuki Takeda, Atsushi Kuroiwa, Etsuro Yamaha, Chiharu Ueguchi, Akiko Imamura, Tomomi Suzuki, Sumito Koshida, Takatoshi Kiba, Minori Shinya and Masami Wakahara and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Toshiro Mizuno

55 papers receiving 1.3k citations

Peers

Countries citing papers authored by Toshiro Mizuno

Since Specialization

Citations

This map shows the geographic impact of Toshiro Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiro Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiro Mizuno more than expected).

Fields of papers citing papers by Toshiro Mizuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiro Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiro Mizuno. The network helps show where Toshiro Mizuno may publish in the future.

Co-authorship network of co-authors of Toshiro Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiro Mizuno. A scholar is included among the top collaborators of Toshiro Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiro Mizuno. Toshiro Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of MAGE‐A4 expression in breast cancer and its impact on prognosis 2024 ·Cancer Science ·(unknown), Kanako Saito, (unknown), Yuji Kozuka, (unknown), Yuki Nishimura, Makoto Ishitobi, Mikiya Ishihara, Toshiro Mizuno, Isao Tawara, (unknown), Tomoko Ogawa, (unknown), Yoshihiro Miyahara	0
2	Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03) 2023 ·Breast Cancer Research and Treatment ·Kokoro Kobayashi, Norikazu Masuda, Toshiro Mizuno, (unknown), Yutaka Tokuda, Tetsuhiro Yoshinami, Hidetoshi Kawaguchi, Shoichiro Ohtani, Toshiaki Saeki, Masakazu Toi, Masahiro Takeuchi, Yoshinori Ito	0
3	Preliminary results of reduced myocardial blood flow in the subacute phase after radiation therapy for thoracic esophageal cancer: A quantitative analysis with stress dynamic myocardial computed tomography perfusion imaging 2022 ·Radiotherapy and Oncology ·Akinori Takada, Yasutaka Ichikawa, Satoshi Nakamura, (unknown), Tomoko Kawamura, (unknown), (unknown), (unknown), Toshiro Mizuno, Kakuya Kitagawa, Masaki Ishida, Noriko Ii, Yoshihito Nomoto, Hajime Sakuma	2
4	P1-5 Retrospective analysis of the efficacy and safety of nivolumab in patients with treatment-refractory esophageal cancer 2021 ·Annals of Oncology ·Toshiaki Kobayashi, (unknown), (unknown), Akira Tsunoda, (unknown), Mikiya Ishihara, Kanako Saito, Yoshiki Yamashita, Toshiro Mizuno	0
5	P1-9 Retrospective analysis of the efficacy and safety of FOLFOX in patients with esophageal cancer 2021 ·Annals of Oncology ·(unknown), Akira Tsunoda, (unknown), (unknown), Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Yoshiki Yamashita, Toshiro Mizuno	0
6	CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression 2020 ·Oncology Letters ·(unknown), Kanako Saito, Yuji Kozuka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Makoto Ishitobi, (unknown), (unknown), Mikiya Ishihara, Toshiro Mizuno, Tomoko Ogawa, Naoyuki Katayama	10
7	First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors 2020 ·Cancer Immunology Immunotherapy ·Mikiya Ishihara, (unknown), Yoshihiro Miyahara, Daisuke Muraoka, Naozumi Harada, Shinichi Kageyama, Takeshi Sasaki, (unknown), Norihito Soga, Katsunori Uchida, Taizo Shiraishi, Eiichi Sato, Hideki Kanda, Toshiro Mizuno, Gill Webster, Hiroaki Ikeda, Naoyuki Katayama, Yoshiki Sugimura, Hiroshi Shiku	21
8	Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study 2020 ·British Journal of Cancer ·Hirofumi Mukai, Takeshi Yamaguchi, Masato Takahashi, Yasuo Hozumi, Tomomi Fujisawa, Shozo Ohsumi, Hiromitsu Akabane, Reiki Nishimura, Tsutomu Takashima, Young‐Jin Park, Yasuaki Sagara, Tatsuya Toyama, Shigeru Imoto, Toshiro Mizuno, Satoshi Yamashita, Satoshi Fujii, Yukari Uemura	13
9	Gastric metastasis resembling linitis plastica 17 years after lobular breast cancer 2019 ·Digestive and Liver Disease ·Yasuhiko Hamada, Kyosuke Tanaka, (unknown), Toshiro Mizuno	1
10	First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer 2019 ·Case Reports in Oncology ·(unknown), Mikiya Ishihara, Yoshihiro Miyahara, Junko Nakamura, Yuji Kozuka, Motoh Iwasa, Akira Tsunoda, Yoshiki Yamashita, Kanako Saito, Toshiro Mizuno, Hiroshi Shiku, Naoyuki Katayama	30
11	Spontaneous Tumor Lysis Syndrome in a Patient with a Dedifferentiated Endometrial Adenocarcinoma 2017 ·Case Reports in Oncological Medicine ·Shinichi Harada, (unknown), (unknown), Tetsuya Murata, Toshiro Mizuno, Keiki Kawakami	4
12	Two cases of clinical tumor lysis syndrome following lapatinib in HER2 positive breast cancer 2015 ·Annals of Oncology ·(unknown), Mikiya Ishihara, Satoshi Tamaru, Yoshiki Yamashita, (unknown), (unknown), Yumiko Sugawara, Toshiro Mizuno, Naoyuki Katayama	1
13	Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study 2011 ·Breast Cancer ·Masataka Sawaki, Hirofumi Mukai, Nahomi Tokudome, Takahiro Nakayama, Naruto Taira, Toshiro Mizuno, Yutaka Yamamoto, (unknown), Toru Watanabe, Yukari Uemura, Yasuo Ohashi	11
14	Pseudo-Response Regulator (PRR) Homologues of the Moss Physcomitrella patens: Insights into the Evolution of the PRR Family in Land Plants 2010 ·DNA Research ·Santosh B. Satbhai, Takafumi Yamashino, Ryo Okada, (unknown), Toshiro Mizuno, (unknown), T. Itoh, Masaki Tomita, S. Otsuki, Setsuyuki Aoki	43
15	Rhythmic and Light-Inducible Appearance of Clock-Associated Pseudo-Response Regulator Protein PRR9 Through Programmed Degradation in the Dark in Arabidopsis thaliana 2007 ·Plant and Cell Physiology ·Shogo Ito, (unknown), Takatoshi Kiba, Takafumi Yamashino, Toshiro Mizuno	42
16	The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone 2006 ·Supportive Care in Cancer ·Toshiro Mizuno, Noriyuki Katsumata, Hirofumi Mukai, Chikako Shimizu, Masashi Ando, Toru Watanabe	7
17	Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan 2003 ·Supportive Care in Cancer ·Akira Inoue, Yasuhide Yamada, Yasuhiro Matsumura, Yasuhiro Shimada, Kei Muro, Masahiro Gotoh, Tetsuya Hamaguchi, Toshiro Mizuno, Kuniaki Shirao	41
18	Removal of vegetal yolk causes dorsal deficencies and impairs dorsal-inducing ability of the yolk cell in zebrafish 1999 ·Mechanisms of Development ·Toshiro Mizuno, Etsuro Yamaha, Atsushi Kuroiwa, Hiroyuki Takeda	84
19	Zebrafish wnt11: pattern and regulation of the expression by the yolk cell and No tail activity 1998 ·Mechanisms of Development ·Ryosuke Makita, Toshiro Mizuno, Sumito Koshida, Atsushi Kuroiwa, Hiroyuki Takeda	75
20	Histidine-Containing Phosphotransfer (HPt) Signal Transducers Implicated in His-to-Asp Phosphorelay in Arabidopsis 1998 ·Plant and Cell Physiology ·Tomomi Suzuki, Akiko Imamura, Chiharu Ueguchi, Toshiro Mizuno	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact